Trial begins of nasal vaccine for Alzheimer disease
Nov 18, 2021
Phase 1 trial will include 16 patients ages 60 to 85 years who have early, symptomatic Alzheimer disease but are otherwise in good health
New symptoms ID’d that may indicate pancreatic cancer
Nov 18, 2021
Additional symptoms can be used to update QCancer, a risk prediction model that helps physicians identify patients at high risk for cancer
FDA approves virtual reality system to ease back pain
Nov 17, 2021
EaseVRx system uses number of cognitive behavioral therapy methods to achieve pain relief
Hypertension may increase risk for late-onset epilepsy
Nov 17, 2021
After adjustment for prevalent and interim stroke, risk for developing epilepsy increased almost twofold
ACS: Patients can be evaluated for stroke and trauma with STRAUMA Alert
Nov 03, 2021
While the approach adds a few minutes for time to CT, there was no impact on start of treatment
Mirtazapine does not reduce agitation in dementia patients
Nov 03, 2021
In randomized, double-blind trial, no difference seen in scores for agitated behaviors at 12 weeks with mirtazapine versus placebo
Guideline addresses diagnosis, evaluation of chest pain in adults
Nov 02, 2021
Chest pain can extend beyond the chest; patients experiencing chest pain or equivalent should seek medical help immediately
USPSTF still advises against COPD screening for asymptomatic adults
Nov 02, 2021
There is no net benefit for screening asymptomatic adults for COPD, the U.S. Preventive Services Task Force has concluded in its latest recommendation.
Parkinson disease mortality up in U.S. from 1999 to 2019
Oct 28, 2021
Increases seen across all age groups, both sexes, various racial/ethnic groups, different urban/rural classifications
Risk factors ID’d for conversion from RIS to multiple sclerosis
Oct 18, 2021
For radiologically isolated syndrome, younger age, spinal cord lesions, gadolinium-enhancing lesions at time of index scan tied to increased risk